Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C22H28NO3.Br |
| Molecular Weight | 434.367 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Br-].CC[N+]1(CC)CCC(C1)OC(=O)C(O)(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=GGMMWVHTLAENAS-UHFFFAOYSA-M
InChI=1S/C22H28NO3.BrH/c1-3-23(4-2)16-15-20(17-23)26-21(24)22(25,18-11-7-5-8-12-18)19-13-9-6-10-14-19;/h5-14,20,25H,3-4,15-17H2,1-2H3;1H/q+1;/p-1
| Molecular Formula | C22H27NO3 |
| Molecular Weight | 353.4547 |
| Charge | 0 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
| Molecular Formula | BrH |
| Molecular Weight | 80.912 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/393571 | https://www.ncbi.nlm.nih.gov/pubmed/758136
Curator's Comment: Benzilonium, is an anticholinergic with minimal central nervous effects
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
30 mg single, intravenous Highest studied dose Dose: 30 mg Route: intravenous Route: single Dose: 30 mg Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
Other AEs: Shock... Other AEs: Shock (grade 2, 13%) Sources: |
35 mg 2 times / day multiple, oral Highest studied dose Dose: 35 mg, 2 times / day Route: oral Route: multiple Dose: 35 mg, 2 times / day Sources: |
healthy, ADULT Health Status: healthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Shock | grade 2, 13% | 30 mg single, intravenous Highest studied dose Dose: 30 mg Route: intravenous Route: single Dose: 30 mg Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effect of fundic distension on gastric bicarbonate secretion in man. | 1987-06 |
|
| Do enkephalins participate in vagal activation of gastric acid secretion in man? | 1987-01 |
|
| Studies on gastric bicarbonate secretion in man. | 1987 |
|
| Effect of selective and non-selective antimuscarinics on rectosigmoid motility and gastrointestinal transit. | 1985-11 |
|
| Intragastric bacteria and nitrite after short-term treatment with different doses of antimuscarinic drugs. | 1984-01 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/393571
Curator's Comment: Benzilonium has also being used orally: https://www.ncbi.nlm.nih.gov/pubmed/7257013
Intravenous injection of benzilonium bromide in a dose close to 70 ug/kg, and atropine in the low dose of 30 ug/kg inhibited the acid response to sham feeding by about 65%.
Route of Administration:
Intravenous
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:59:11 GMT 2025
by
admin
on
Mon Mar 31 17:59:11 GMT 2025
|
| Record UNII |
EMB5M4GMHP
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29704
Created by
admin on Mon Mar 31 17:59:11 GMT 2025 , Edited by admin on Mon Mar 31 17:59:11 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m581
Created by
admin on Mon Mar 31 17:59:11 GMT 2025 , Edited by admin on Mon Mar 31 17:59:11 GMT 2025
|
PRIMARY | Merck Index | ||
|
107530
Created by
admin on Mon Mar 31 17:59:11 GMT 2025 , Edited by admin on Mon Mar 31 17:59:11 GMT 2025
|
PRIMARY | |||
|
1050-48-2
Created by
admin on Mon Mar 31 17:59:11 GMT 2025 , Edited by admin on Mon Mar 31 17:59:11 GMT 2025
|
PRIMARY | |||
|
C72943
Created by
admin on Mon Mar 31 17:59:11 GMT 2025 , Edited by admin on Mon Mar 31 17:59:11 GMT 2025
|
PRIMARY | |||
|
100000086384
Created by
admin on Mon Mar 31 17:59:11 GMT 2025 , Edited by admin on Mon Mar 31 17:59:11 GMT 2025
|
PRIMARY | |||
|
66247
Created by
admin on Mon Mar 31 17:59:11 GMT 2025 , Edited by admin on Mon Mar 31 17:59:11 GMT 2025
|
PRIMARY | |||
|
EMB5M4GMHP
Created by
admin on Mon Mar 31 17:59:11 GMT 2025 , Edited by admin on Mon Mar 31 17:59:11 GMT 2025
|
PRIMARY | |||
|
1156
Created by
admin on Mon Mar 31 17:59:11 GMT 2025 , Edited by admin on Mon Mar 31 17:59:11 GMT 2025
|
PRIMARY | |||
|
213-885-5
Created by
admin on Mon Mar 31 17:59:11 GMT 2025 , Edited by admin on Mon Mar 31 17:59:11 GMT 2025
|
PRIMARY | |||
|
SUB05749MIG
Created by
admin on Mon Mar 31 17:59:11 GMT 2025 , Edited by admin on Mon Mar 31 17:59:11 GMT 2025
|
PRIMARY | |||
|
DTXSID1057612
Created by
admin on Mon Mar 31 17:59:11 GMT 2025 , Edited by admin on Mon Mar 31 17:59:11 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110788
Created by
admin on Mon Mar 31 17:59:11 GMT 2025 , Edited by admin on Mon Mar 31 17:59:11 GMT 2025
|
PRIMARY | |||
|
C004460
Created by
admin on Mon Mar 31 17:59:11 GMT 2025 , Edited by admin on Mon Mar 31 17:59:11 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |